Adamas Pharmaceuticals Inc Asset Turnover Ratio (ADMS), as of third quarter 2021, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Adamas Pharmaceuticals Inc  (NASDAQ: ADMS)
 

Adamas Pharmaceuticals Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Adamas Pharmaceuticals Inc asset turnover ratio, the ability of Adamas Pharmaceuticals Inc's assets to generate revenue in the third quarter 2021, increased sequentially to 0.63 in the third quarter (Sep 30 2021), yet the ratio remained below the average, as ADMS's position remain challenging.

Within sector 80 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the III Quarter 2021, to 1582, from total ranking in the second quarter 2021 at 1697.

Asset Turnover Ratio Definition



ADMS Asset Turnover Ratio (Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
Y / Y Asset Change 9.75 % 15.11 % 20.16 % -25.81 % -26.03 %
Y / Y Revenue Change 28.35 % 16.91 % 33.35 % 28.52 % 44.81 %
Asset Turnover Ratio (TTM) 0.63 0.6 0.6 0.6 0.52
ADMS's Total Ranking # 1582 # 1697 # 1380 # 1423 # 1380
Seq. Asset Change -4.61 % -11.22 % 43.77 % -9.86 % 0.04 %
Seq. Revenue Change 17.86 % 13.78 % -8.09 % 4.13 % 7.35 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 81
Healthcare Sector # 178
Overall Market # 1582

Asset Turnover Ratio Statistics
High Average Low
200.7 26.92 0.79
(Dec 31 2014)   (Dec 31 2016)







Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2021, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2021 Assets at quarter ending Sep 30 2021
Champions Oncology Inc   1.68 $ 44.415  Millions$ 26.437  Millions
Kewaunee Scientific Corporation  1.66 $ 150.570  Millions$ 90.896  Millions
Precision Optics Corporation Inc   1.63 $ 10.253  Millions$ 6.283  Millions
Progyny Inc   1.58 $ 473.369  Millions$ 299.318  Millions
Sunlink Health Systems Inc   1.58 $ 47.237  Millions$ 29.883  Millions
Encision Inc   1.53 $ 8.431  Millions$ 5.529  Millions
Henry Schein Inc   1.52 $ 12,236.224  Millions$ 8,024.317  Millions
Chemed Corporation  1.52 $ 2,131.572  Millions$ 1,398.743  Millions
Vaso Corporation  1.49 $ 69.772  Millions$ 46.834  Millions
Zynex inc   1.46 $ 115.540  Millions$ 79.208  Millions
Vystar Corporation  1.43 $ 30.264  Millions$ 21.110  Millions
Vycor Medical Inc   1.37 $ 1.390  Millions$ 1.015  Millions
Mimedx Group Inc   1.37 $ 259.754  Millions$ 190.129  Millions
Organogenesis Holdings Inc   1.33 $ 446.308  Millions$ 334.916  Millions
Idexx Laboratories Inc  1.33 $ 3,135.208  Millions$ 2,354.960  Millions
Amedisys Inc  1.32 $ 2,205.500  Millions$ 1,669.404  Millions
Innovage Holding Corp   1.31 $ 658.305  Millions$ 503.914  Millions
American Bio Medica Corporation  1.31 $ 2.486  Millions$ 1.903  Millions
Acura Pharmaceuticals inc  1.29 $ 2.245  Millions$ 1.739  Millions
Magellan Health inc   1.26 $ 4,149.567  Millions$ 3,291.935  Millions
Biocept Inc   1.25 $ 65.784  Millions$ 52.575  Millions
International Stem Cell Corporation  1.25 $ 6.808  Millions$ 5.464  Millions
Semler Scientific inc   1.24 $ 53.558  Millions$ 43.062  Millions
Alpha Pro Tech Ltd   1.24 $ 84.461  Millions$ 68.219  Millions
Dynatronics Corporation  1.23 $ 47.967  Millions$ 39.018  Millions
Option Care Health Inc   1.23 $ 3,316.159  Millions$ 2,698.203  Millions
Procyon Corporation  1.21 $ 4.663  Millions$ 3.863  Millions
Fuse Medical Inc   1.21 $ 21.369  Millions$ 17.725  Millions
Hca Healthcare Inc   1.20 $ 57,981.000  Millions$ 48,123.250  Millions
Co diagnostics Inc   1.19 $ 104.629  Millions$ 87.626  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.